Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Evaluation of the involvement of innate lymphoid cells in mucosal immunity and the immunopathology of inflammatory bowel disease

FY 2010-11

Summary
The gastrointestinal (GI) tract is constantly exposed to intestinal microbes. While one might speculate that it would be advantageous to keep this site sterile, it is now clear that microbial colonization is important to the development and functioning of this organ as well as for the development of a robust immune system. Therefore there is a symbiotic relationship where the host provides a niche for microbes and the beneficial relationship to the host is that these microbes help to educate the immune response. How tolerance to these microorganisms is overturned to respond to invasive pathogens is not completely understood, and is the subject of intense research. Unfortunately, there are chronic clinical presentations of overactive inflammatory responses in the GI tract that are caused by a disrupted relationship between the host and these microbes. Chronic inflammatory reactions ultimately lead to a diagnosis of Crohn's disease or ulcerative colitis, which are major clinical challenges in Canada. Dr. Powrie's lab at the University of Oxford is a world leader in understanding the regulation of the immune system within the GI tract, with an emphasis on understanding these diseases and deciphering the involvement of both host genetic as well as environmental factors. Recently this group made the surprising discovery that a group of relatively uncharacterized cells, known as innate lymphoid cells drive intestinal inflammation in animal models of disease, published in Nature April 2010. My research will help determine the mechanism of inflammation that drives these cells toward disease progression in order to identify drug targets, as well as to determine the influence that microbial interactions have on these cells in order to understand how to manage these microbial populations to control inflammation. Each patient is unique and the goal of this research is to understand the disease process in greater detail in order to ultimately direct patient-specific therapies.
Program
CIHR Fellowship
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
226433
Name
Long Elizabeth M
Country
United Kingdom
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Evaluation of the involvement of innate lymphoid cells in mucosal immunity and the immunopathology of inflammatory bowel disease
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adaptive Immunity; Cytokine Networks; Gastrointestinal Inflammation; Inflammation; Innate Immunity; Innate Lymphoid Cells
Abstract
The gastrointestinal (GI) tract is constantly exposed to intestinal microbes. While one might speculate that it would be advantageous to keep this site sterile, it is now clear that microbial colonization is important to the development and functioning of this organ as well as for the development of a robust immune system. Therefore there is a symbiotic relationship where the host provides a niche for microbes and the beneficial relationship to the host is that these microbes help to educate the immune response. How tolerance to these microorganisms is overturned to respond to invasive pathogens is not completely understood, and is the subject of intense research. Unfortunately, there are chronic clinical presentations of overactive inflammatory responses in the GI tract that are caused by a disrupted relationship between the host and these microbes. Chronic inflammatory reactions ultimately lead to a diagnosis of Crohn's disease or ulcerative colitis, which are major clinical challenges in Canada. Dr. Powrie's lab at the University of Oxford is a world leader in understanding the regulation of the immune system within the GI tract, with an emphasis on understanding these diseases and deciphering the involvement of both host genetic as well as environmental factors. Recently this group made the surprising discovery that a group of relatively uncharacterized cells, known as innate lymphoid cells drive intestinal inflammation in animal models of disease, published in Nature April 2010. My research will help determine the mechanism of inflammation that drives these cells toward disease progression in order to identify drug targets, as well as to determine the influence that microbial interactions have on these cells in order to understand how to manage these microbial populations to control inflammation. Each patient is unique and the goal of this research is to understand the disease process in greater detail in order to ultimately direct patient-specific therapies.
Competitiondate
201102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Long, Elizabeth M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Direct Payment - $150,000 Grant (2010-11) | Canada Spends